The Proteomics of hypothalmic obese after treatment of brain tumor

The Proteomics of hypothalmic obese after treatment of brain tumor - Proteomics of hypothalmic obese in brain tumor

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019063

Enrollment

Registered

2015-09-18

Start date

2015-09-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Craniopharyngioma

Interventions

collect blood samples from hypothalmic obese patients

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1 hypothalmic obese patients after treatment of craniopharyngioma 2 Patients of common obesity

Exclusion criteria

Exclusion criteria: Patient withholding assent

Design outcomes

Primary

Measure	Time frame
to investigate substances responsible for hypothalmic obese	—

Countries

Japan

Contacts

Public ContactShinichi Tsujimoto

Yokohama city university Department of Pediatrics

shnch10090218@gmail.com045-787-2800

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026